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The AIDS pandemic ranks among the most 
devastating  public  health  catastrophes  in 
human history, one whose full impact has 
yet to be realized (Anthony and Fauci, 2008). 
Today there is no end in sight. Globally, a stag-
gering 33–60 million people are estimated to 
be living with HIV/AIDS (UNAIDS, 2008). 
Each year approximately 2.7 million more 
people  worldwide  become  infected  with 
HIV and 2 million die of AIDS. In the U.S., 
the data is equally staggering. Over one mil-
lion people are estimated to be living with 
HIV/AIDS. In 2007, approximately 56,300 
people  were  newly  infected  (Hall  et  al., 
2008). Epidemic trends also highlight the 
continued and increasing spread of the HIV 
virus among special populations, including 
women, members of minority communi-
ties, children, and older adults (Centers for 
Disease Control and Prevention, 2007). The 
devastation caused by AIDS has surpassed 
even the most dismal predictions of the early 
1980s. Yet, no statistics, however alarming, 
can  adequately  convey  the  suffering  and 
human trial these numbers represent.
The  involvement  of  psychiatrists  in 
the diagnosis and treatment of AIDS and 
HIV infection is essential, as this disease 
binds  both  internal  medicine  and  psy-
chiatry  together  like  few  other  diseases 
have the potential to do. The course of 
HIV infection is associated with a variety 
of  emotional,  cognitive,  and  neurologi-
cal disturbances which may be caused by 
premorbid psychiatric disorders; psycho-
logical stress, opportunistic infections or 
neoplasms; or by medications used in the 
treatment of HIV. Clinical experience and 
research also provide substantial evidence 
that HIV directly infects the brain soon 
after initial infection, which can result in 
central nervous system (CNS) impairment. 
HIV has been described as “a neuropsy-
chiatric  disease  with  systemic  manifes-
tations”  (Ferrando  and  Freyberg,  2008) 
diagnose in the medically ill (Harold et al., 
1998); and (10) as HIV/AIDS is becoming 
an increasingly chronic disorder with the 
improvement  of  treatments  and  longer 
survival times.
It is essential, therefore, that psychia-
trists receive comprehensive education in 
the direct care and support for the HIV 
patient. Psychiatrists must be prepared to 
manage the complex medical issues that 
may lead to CNS dysfunction, assess and 
monitor patients for the neuropsychiat-
ric consequences of HIV, aggressively treat 
substance  abuse  and  other  psychiatric 
disorders, manage the co-administration 
of psychotropic drugs and antiretroviral 
agents, review antiretroviral regimens for 
agents that cause CNS side effects; facilitate 
the appropriate care of HIV patients with 
severe mental illness, promote treatment 
adherence, and respond to complex ethical 
and medical issues. And as the epidemic 
changes demographically, physicians will 
need to play an important role in manag-
ing the needs of specific patient popula-
tions, including women, adolescents, gay, 
lesbian, bisexual, and transgender (GLBT) 
people, racial and ethnic minorities, and 
older adults. Finally, physicians must also 
be prepared for challenges that accom-
pany clinical advances and the introduc-
tion of highly active antiretroviral therapy 
(HAART). Potent antiretroviral regimens 
and combination therapies have shown 
tremendous advances in improving sys-
temic  health,  but  a  similar  reduction 
specifically  in  HIV-1  associated  neuro-
cognitive impairment has not been noted. 
These issues bind practitioners of multiple 
medical specialties including psychiatry, 
internal  medicine,  and  neurology—and 
competent  practitioners  in  HIV-AIDS 
medicine  must  be  comfortable  with  a 
knowledge base that transcends any one 
particular specialty.
whose  assault  on  the  brain  and  human 
body  requires  the  participation  of  both 
psychiatrists  and  internists  throughout 
the course of illness. Missed diagnoses by 
inadequately trained providers can lead to 
irreversible damage.
Several important aspects of HIV care 
and treatment place those with a combined 
understanding of internal medicine and 
psychiatry at the forefront of this epidemic, 
including, but not limited to: (1) psychiat-
ric disorders can increase an individual’s 
risk  of  acquiring  sexually  transmitted 
diseases, including HIV (Ramrakha et al., 
2000); (2) pre-existing mental disorders 
(including substance abuse) can predate 
and/or  complicate  HIV-related  illness 
(Cournos et al., 2001); (3) neuropsychiatric 
complications and psychiatric illness can 
affect adherence to antiretroviral therapy 
regimens (Farber and McDaniel, 1999); (4) 
new   antiretroviral treatments and combi-
nation therapies can affect the CNS and/or 
contribute to the development of psychi-
atric side effects/symptoms (Tantisiriwat 
et al., 1999); (5) individuals with waning 
immunity and high viral loads may be at 
particular risk for the HIV-related CNS 
complications that can cause acute mental 
status changes (Álvarez-Segura et al., 2008); 
(6) the proportion of mental health and/or 
substance abuse disorders among people 
living with HIV/AIDS is nearly five times 
greater than the proportion found in the 
general population (Bing et al., 2001); (7) 
persons living with a severe mental illness 
(SMI) are disproportionately vulnerable 
(as high as 23%) to infection with HIV and 
other sexually transmitted diseases (Weiser 
et al., 2004); (8) racial and ethnic minori-
ties, who bear a disproportionately higher 
burden of HIV, suffer disproportionately 
from mental disorders; (Hall et al., 2009) 
(9) psychiatric syndromes can be especially 
challenging  to  recognize  and  accurately Fernandez and Goforth  Medicine-psychiatry HIV future directions
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Hope is in the air for integrating both 
HIV/AIDS medicine and HIV/AIDS behav-
ioral health. The old adage “Mens sana in 
corporae sanae” (a sound mind in a sound 
tional change in HIV/AIDS care that seeks 
to  incorporate  knowledge  from  multiple 
medical specialties into a new paradigm of 
care for HIV seropositive patients.
body) still holds true for HIV/AIDS – in 
fact, it is true for all health issues. This is 
our goal with Frontiers in HIV and AIDS 
in Psychiatry - to bring about transforma-